1
|
Nguyen VT, Law MG and Dore GJ: Hepatitis
B-related hepato-cellular carcinoma: Epidemiological
characteristics and disease burden. J Viral Hepat. 16:453–463.
2009. View Article : Google Scholar : PubMed/NCBI
|
2
|
Rabe C, Cheng B and Caselmann WH:
Molecular mechanisms of hepatitis B virus-associated liver cancer.
Dig Dis. 19:279–282. 2001. View Article : Google Scholar
|
3
|
Yoshikawa H, Matsubara K, Qian GS, Jackson
P, Groopman JD, Manning JE, Harris CC and Herman JG: SOCS-1, a
negative regulator of the JAK/STAT pathway, is silenced by
methylation in human hepatocellular carcinoma and shows
growth-suppression activity. Nat Genet. 28:29–35. 2001. View Article : Google Scholar : PubMed/NCBI
|
4
|
Park IY, Sohn BH, Yu E, Suh DJ, Chung YH,
Lee JH, Surzycki SJ and Lee YI: Aberrant epigenetic modifications
in hepatocarcinogenesis induced by hepatitis B virus X protein.
Gastroenterology. 132:1476–1494. 2007. View Article : Google Scholar : PubMed/NCBI
|
5
|
Wang ZG and Wu JX: DNA methyltransferase:
Classification, research progress. Yi Chuan. 31:903–912. 2009.In
Chinese. View Article : Google Scholar : PubMed/NCBI
|
6
|
Jang SJ, Soria JC, Wang L, Hassan KA,
Morice RC, Walsh GL, Hong WK and Mao L: Activation of melanoma
antigen tumor antigens occurs early in lung carcinogenesis. Cancer
Res. 61:7959–7963. 2001.PubMed/NCBI
|
7
|
Roman-Gomez J, Jimenez-Velasco A,
Castillejo JA, Agirre X, Barrios M, Navarro G, Molina FJ, Calasanz
MJ, Prosper F, Heiniger A and Torres A: Promoter hypermethylation
of cancer-related genes: A strong independent prognostic factor in
acute lymphoblastic leukemia. Blood. 104:2492–2498. 2004.
View Article : Google Scholar : PubMed/NCBI
|
8
|
Chen L, Zhu Z, Sun X, Dong XY, Wei J, Gu
F, Sun YL, Zhou J, Dong JT and Fu L: Down-regulation of tumor
suppressor gene FEZ1/LZTS1 in breast carcinoma involvespromoter
methylation and associates with metastasis. Breast Cancer Res
Treat. 116:471–478. 2009. View Article : Google Scholar
|
9
|
Mendez N, Orenes-Piñero E, Gaspar M,
Fierro M, Ecke T, Gil M, Palou J, et al: Discovery of the
methylation of the metastasis suppressor gene, KISS-1, in bladder
cancer. J Urology. 181:3742009. View Article : Google Scholar
|
10
|
Yu J, Ni M, Xu J, Zhang H, Gao B, Gu J,
Chen J, Zhang L, Wu M, Zhen S and Zhu J: Methylation profiling of
twenty promoter- CpG islands of genes which may contribute to
hepatocellular carcinogenesis. BMC Cancer. 2:292002. View Article : Google Scholar
|
11
|
Murakami S: Hepatitis B Virus X Protein:
Structure, function and biology. Intervirology. 42:81–99. 1999.
View Article : Google Scholar : PubMed/NCBI
|
12
|
Zhao H, Liu KG, Shang HL, et al: The
correlation of HBx and VEGF expression with angiogenesis and
metastasis in HBV related hepatocelular carcinoma. Chin Hepatol.
1:15–18. 2010.
|
13
|
Li W, Miao X, Qi Z, Zeng W, Liang J and
Liang Z: Hepatitis B virus x protein upregulates HSP90 alpha
expression via activation of c-myc in human hepatocarcinoma cell
line, HepG2. Virol J. 7:452010. View Article : Google Scholar
|
14
|
Gui Y, Yeganeh M, Ramanathan S, Leblanc C,
Pomerleau V, Ferbeyre G, Saucier C and Ilangumaran S: SOCS-1
controls liver regeneration by regulating HGF signaling in
hepatocytes. J Hepatol. 55:1300–1308. 2011. View Article : Google Scholar : PubMed/NCBI
|
15
|
Liu W, Li X, Chu ES, Go MY, Xu L, Zhao G,
Li L, Dai N, Si J, Tao Q, Sung JJ and Yu J: Paired box gene 5 is a
novel tumor suppressor in hepatocellular carcinoma through
interaction with p53 signaling pathway. Hepatology. 53:843–853.
2011. View Article : Google Scholar : PubMed/NCBI
|
16
|
Yoshida T, Ogata H, Kamio M, Joo A,
Shiraishi H, Tokunaga Y, Sata M, Nagai H and Yoshimura A: SOCS1 is
a suppressorof liver fibrosis and hepatitis-induced carcinogenesis.
J Exp Med. 199:1701–1707. 2004. View Article : Google Scholar : PubMed/NCBI
|
17
|
Zhang YJ, Li H, Wu HC, Shen J, Wang L, Yu
MW, Lee PH, Bernard Weinstein I and Santella RM: Silencing of
Hint1, a novel tumor suppressor gene, by promoter hypermethylation
in hepato-cellular carcinoma. Cancer Lett. 275:277–284. 2009.
View Article : Google Scholar
|
18
|
Venkitachalam S, Chueh FY, Leong KF,
Pabich S and Yu CL: Suppressor of cytokine signaling 1 interacts
with oncogenic lymphocyte-specific protein tyrosine kinase. Oncol
Rep. 25:677–683. 2011.PubMed/NCBI
|
19
|
Peng XC, Ma HY and Wang CQ: Aberrant
methylation of suppressor of Ccytokine signaling-1 gene in human
gastric carcinomas. Journal of Yangtze University (Natural Science
Edition). 5:5–8. 2008.
|
20
|
Chen NP, Jiang YG, Miao H, et al:
Expression and clinical significance of SOSC-1 in human
hepatocellular cancer. J Exp Surg. 2:845–847. 2008.
|
21
|
Chu PY, Yeh CM, Hsu NC, Chang YS, Chang JG
and Yeh KT: Epigenetic alteration of the SOCS-1 gene in
hepatocellular carcinoma. Swiss Med Wkly. 140:w130652010.
|
22
|
Tamiya T, Kashiwagi I, Takahashi R,
Yasukawa H and Yoshimura A: Suppressors of cytokine signaling
(SOCS) proteins and JAK/STAT pathways: regulation of T-cell
inflammation by SOCS1 and SOCS3. Arterioscler Thromb Vasc Biol.
31:980–985. 2011. View Article : Google Scholar : PubMed/NCBI
|
23
|
Kiran M, Chawla YK and Kaur J: Methylation
profiling of tumor suppressor genes and oncogenes in hepatitis
virus-related hepatocellular carcinoma in northern India. Cancer
Genet Cytogenet. 195:112–119. 2009. View Article : Google Scholar : PubMed/NCBI
|
24
|
Nomoto S, Kinoshita T, Kato K, Otani S,
Kasuya H, Takeda S, Kanazumi N, Sugimoto H and Nakao A:
Hypermethylation of multiple genes as clonal markers in
multicentric hepatocellular carcinoma. Br J Cancer. 97:1260–1265.
2007. View Article : Google Scholar : PubMed/NCBI
|
25
|
Ko E, Kim SJ, Joh JW, Park CK, Park J and
Kim DH: CpG island hypermethylation of SOCS-1 gene is inversely
associated with HBV infection in hepatocellular carcinoma. Cancer
Lett. 271:240–250. 2008. View Article : Google Scholar : PubMed/NCBI
|
26
|
Miyoshi H, Fujie H, Shintani Y, Tsutsumi
T, Shinzawa S, Makuuchi M, Kokudo N, Matsuura Y, Suzuki T, Miyamura
T, et al: Hepatitis C virus core protein exerts an inhibitory
effect on suppressor of cytokine signaling (SOCS)-1 gene
expression. J Hepatol. 43:757–763. 2005. View Article : Google Scholar : PubMed/NCBI
|
27
|
Su PF, Lee TC, Lin PJ, Lee PH, Jeng YM,
Chen CH, Liang JD, Chiou LL, Huang GT and Lee HS: Differential DNA
methylation associated with hepatitis B virus infection in
hepatocellular carcinoma. Int J Cancer. 121:1257–1264. 2007.
View Article : Google Scholar : PubMed/NCBI
|
28
|
Yan J, Lu Q, Dong J, Li X, Ma K and Cai L:
Hepatitis B virus X protein suppresses caveolin-1 expression in
hepatocellular carcinoma by regulating DNA methylation. BMC Cancer.
12:3532012. View Article : Google Scholar : PubMed/NCBI
|
29
|
Zhu YZ, Zhu R, Shi LG, Mao Y, Zheng GJ,
Chen Q and Zhu HG: Hepatitis B virus X protein promotes
hypermethylation of p16(INK4A) promoter through upregulation of DNA
meth-yltransferases in hepatocarcinogenesis. Exp Mol Pathol.
89:268–275. 2010. View Article : Google Scholar : PubMed/NCBI
|
30
|
Liu LM, Luo L, Jing M, et al: HBx in HCC
pathogenesis and biological treatment strategies. World J
Gastroenterol. 13:432–439. 2005.
|
31
|
Zhang YG and Liu BC: Functions of DNA
methyltransferase and methylation in tumor generation. Int J Surg.
35:537–540. 2008.
|
32
|
Zhang JC, Lu J, Li HP, et al: p16 promoter
hypermethylation in the plasma DNA and its possible application in
molecular diagnosis of hepatocellular carcinoma. Zhonghua Jian Yan
Yi Xue Za Zhi. 29:895–898. 2006.
|
33
|
Schagdarsurengin U, Wikens L, Steinemann
D, Flemming P, Kreipe HH, Pfeifer GP, Schlegelberger B and Dammann
R: Frequent epigenetic inactivation of the RASSF1A gene in
hepatocellular carcinoma. Oncogene. 22:1866–1871. 2003. View Article : Google Scholar : PubMed/NCBI
|
34
|
Yang B, Guo M, Herman JG and Clark DP:
Aberrant promoter methylation profiles of tumor suppressor genes in
hepatocellular carcinoma. Am J Pathol. 163:1101–1107. 2003.
View Article : Google Scholar : PubMed/NCBI
|
35
|
Wang DF, Liu S, Liu QY, et al: The
relationship between HBx and methylation status of MATs promoters
in hepatocellular carcinoma. J Exp Surg. 28:242–244. 2011.
|
36
|
Jung JK, Arora P, Pagano JS and Jang KL:
Expression of DNA methytranferase 1 is activated by hepatitis B
virus X protein via a regulatory circuit involving the
p16INK4a-cyclin D1-CDK 46/pRb-E2F1 pathway. Cancer Res.
67:5771–5778. 2007. View Article : Google Scholar : PubMed/NCBI
|
37
|
Zheng DL, Zhang L, Cheng N, Xu X, Deng Q,
Teng XM, Wang KS, Zhang X, Huang J and Han ZG: Epigenetic
modification induced by hepatitis B virus X protein via interaction
with de novo DNA methyltransferase DNMT3A. J Hepatol. 50:377–387.
2009. View Article : Google Scholar
|